A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

NCT06625671 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: DB-2304
DRUG: Placebo
DRUG: Prednisone

Sponsor

DualityBio Inc.